Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery

28Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We present the discovery of a nano-sized protein- derived micellar drug delivery system based on the polycationic albumin precursor protein cBSA-147. The anticancer drug doxorubicin (DOX) was efficiently encapsulated into nanosized micelles based on hydrophobic interactions with the polypeptide scaffold. These micelles revealed attractive stabilities in various physiological buffers and a wide pH range as well as very efficient uptake into A549 cells after 1 h incubation time only. In vitro cytotoxicity was five-times increased compared to free DOX also indicating efficient intracellular drug release. In addition, multiple functional groups are available for further chemical modifications. Based on the hydrophobic loading mechanism, various classical anti-cancer drugs, in principle, could be delivered even synergistically in a single micelle. Considering these aspects, this denatured albumin-based drug delivery system represents a highly attractive platform for nanomedicine approaches towards cancer therapy. © The Author(s) 2012.

Cite

CITATION STYLE

APA

Wu, Y., Shih, E. K., Ramanathan, A., Vasudevan, S., & Weil, T. (2012). Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery. Biointerphases, 7(1–4). https://doi.org/10.1007/s13758-011-0005-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free